Performance Status and Quality Life of Patients with Hematopoietic Stem Cell Transplantation According to Period of Survival.
10.5388/aon.2012.12.2.132
- Author:
Hyae Deok WOO
1
;
Jeong Sook PARK
Author Information
1. Yeungnam University Medical Center, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
Quality of Life;
Hematopoietic Stem Cell Transplantation;
Survival;
Leukemia
- MeSH:
Bone Marrow;
Hematopoietic Stem Cell Transplantation;
Hematopoietic Stem Cells;
Hospitals, General;
Humans;
Leukemia;
Outpatients;
Quality of Life
- From:Asian Oncology Nursing
2012;12(2):132-138
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to identify the performance status and quality of life (QOL) of patients after hematopoietic stem cell transplantation (HSCT) according to period of survival. METHODS: Participants consists of 83 HSCT patients who were being treated regularly at out-patient clinic in two general hospitals in D city. Data were collected using questionnaires that were modified by Functional Assessment of Cancer Therapy-Bone Marrow Transplabtation (FACT-BMT) scale and Eastern Cooperative Oncology Group (ECOG). RESULTS: The unrelated HSCT group's survival period was significantly worse than related HSCT group and autologous HSCT group. Performance status of the group with more than 3 years survival was significantly higher than that of the group with less than a year survival. The mean score of total QOL of HSCT patients was 2.69 out of 4. Total QOL was not significantly different among period of survival less than 1 year, 1-3 years, and more than 3 years. But BMT QOL was shown that the group with more than 3 years survival was higher than the groups with less than a year survival. CONCLUSION: Performance status and BMT QOL of the group with less than 1 year survival was significantly lowered than the groups with more than 3 years survival.
